RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 88 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,104,125 | -6.7% | 144,330 | -8.9% | 0.00% | 0.0% |
| Q2 2023 | $1,183,188 | +79.7% | 158,392 | +60.5% | 0.00% | +100.0% |
| Q1 2023 | $658,289 | -12.5% | 98,694 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $752,434 | -26.5% | 97,592 | +1.4% | 0.00% | -50.0% |
| Q3 2022 | $1,024,000 | +27.7% | 96,266 | -2.3% | 0.00% | +100.0% |
| Q2 2022 | $802,000 | +32.8% | 98,520 | +16.7% | 0.00% | 0.0% |
| Q1 2022 | $604,000 | -63.4% | 84,397 | -12.4% | 0.00% | -50.0% |
| Q4 2021 | $1,650,000 | +371.4% | 96,335 | +533.7% | 0.00% | – |
| Q3 2021 | $350,000 | -67.1% | 15,203 | -47.9% | 0.00% | -100.0% |
| Q2 2021 | $1,064,000 | – | 29,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 5,977,631 | $42,800,000 | 100.00% |
| Two Sigma Ventures, LP | 1,806,800 | $12,937,000 | 74.73% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $28,290,000 | 31.54% |
| MV Management XI, L.L.C. | 1,971,908 | $14,119,000 | 9.80% |
| Data Collective IV GP, LLC | 5,941,120 | $42,538,000 | 9.03% |
| ArchPoint Investors | 1,267,430 | $9,075,000 | 3.13% |
| MIC Capital Management UK LLP | 1,388,889 | $9,944,000 | 1.94% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $10,806,000 | 1.09% |
| Samsara BioCapital, LLC | 539,236 | $3,861,000 | 0.97% |
| Pinz Capital Management, LP | 142,168 | $1,018,000 | 0.64% |